Active Ingredient: DAPTOMYCIN
Proprietary Name: DAPTOMYCIN
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A091039
Product Number: 001
Approval Date: Mar 25, 2016
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information